Wellington Management Group’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Sell
161,278
-24,404
-13% -$157K ﹤0.01% 1647
2025
Q4
$1.05M Sell
185,682
-40,715
-18% -$221K ﹤0.01% 1709
2025
Q3
$1.4M Buy
226,397
+90,636
+67% +$530K ﹤0.01% 1713
2025
Q2
$661K Buy
+135,761
New +$480K ﹤0.01% 1776
2025
Q1
Sell
-124,551
Closed -$498K 2039
2024
Q4
$498K Buy
124,551
+4,747
+4% +$26.1K ﹤0.01% 1832
2024
Q3
$835K Buy
119,804
+77,564
+184% +$629K ﹤0.01% 1742
2024
Q2
$240K Buy
+42,240
New +$378K ﹤0.01% 1847
2019
Q4
Sell
-20,826
Closed -$3.23M 2110
2019
Q3
$3.23M Sell
20,826
-707
-3% -$80K ﹤0.01% 1452
2019
Q2
$1.86M Sell
21,533
-5,228
-20% -$570K ﹤0.01% 1642
2019
Q1
$3.69M Sell
26,761
-3,711
-12% -$930K ﹤0.01% 1456
2018
Q4
$12.3M Buy
30,472
+3,524
+13% +$1.66M ﹤0.01% 1130
2018
Q3
$19.1M Buy
26,948
+310
+1% +$195K ﹤0.01% 1099
2018
Q2
$14.2M Buy
26,638
+5,929
+29% +$1.82M ﹤0.01% 1183
2018
Q1
$2.33M Buy
+20,709
New +$6.99M ﹤0.01% 1689

Other funds holding SLDB

Wellington Management Group's SLDB Position: Q1 2026 in Review

Wellington Management Group reduced its Solid Biosciences (SLDB) stake by 13% in Q1 2026, selling an estimated $157K and leaving 161,278 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1647.

Wellington Management Group first reported a position in SLDB in Q1 2018 and has held it in 14 quarters since. The position peaked at $19.1M in Q3 2018. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Wellington Management Group held 161,278 shares of Solid Biosciences worth $1.16M as of Q1 2026.
  • Wellington Management Group sold 24,404 Solid Biosciences shares in Q1 2026, an estimated $157K.
  • Solid Biosciences made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1647 holding.
  • Wellington Management Group first reported a position in Solid Biosciences in Q1 2018 and has held it in 14 quarters since.
  • Wellington Management Group's Solid Biosciences position peaked at $19.1M in Q3 2018.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.